DrugCite
Search

STILNOX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Stilnox Adverse Events Reported to the FDA Over Time

How are Stilnox adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Stilnox, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Stilnox is flagged as the suspect drug causing the adverse event.

Most Common Stilnox Adverse Events Reported to the FDA

What are the most common Stilnox adverse events reported to the FDA?

Fall
123 (3.08%)
Confusional State
67 (1.68%)
Amnesia
66 (1.65%)
Somnolence
66 (1.65%)
Coma
45 (1.13%)
Road Traffic Accident
45 (1.13%)
Somnambulism
45 (1.13%)
Drug Exposure During Pregnancy
43 (1.08%)
Completed Suicide
40 (1%)
Vomiting
40 (1%)
Hyponatraemia
39 (.98%)
Show More Show More
Intentional Overdose
37 (.93%)
Condition Aggravated
36 (.9%)
Drug Interaction
35 (.88%)
Overdose
35 (.88%)
Suicide Attempt
34 (.85%)
Cytolytic Hepatitis
32 (.8%)
Loss Of Consciousness
32 (.8%)
Delirium
31 (.78%)
Multiple Drug Overdose Intentional
29 (.73%)
Death
28 (.7%)
Disorientation
28 (.7%)
Malaise
28 (.7%)
Diarrhoea
27 (.68%)
Nausea
26 (.65%)
Rhabdomyolysis
26 (.65%)
Renal Failure
24 (.6%)
Pyrexia
23 (.58%)
Abnormal Behaviour
22 (.55%)
Aggression
22 (.55%)
Renal Failure Acute
20 (.5%)
Agitation
19 (.48%)
Asthenia
19 (.48%)
Drug Abuser
19 (.48%)
Drug Toxicity
19 (.48%)
Agranulocytosis
18 (.45%)
Cholestasis
18 (.45%)
Depression
18 (.45%)
Anxiety
17 (.43%)
Aphasia
17 (.43%)
C-reactive Protein Increased
17 (.43%)
Dehydration
17 (.43%)
General Physical Health Deteriorati...
17 (.43%)
Hypotension
17 (.43%)
Pruritus
17 (.43%)
Anaemia
16 (.4%)
Drug Ineffective
16 (.4%)
Hallucination
16 (.4%)
Hypertension
16 (.4%)
Peripheral Ischaemia
16 (.4%)
Thrombocytopenia
16 (.4%)
Depressed Level Of Consciousness
15 (.38%)
Disturbance In Attention
15 (.38%)
Fatigue
15 (.38%)
Hyperkalaemia
15 (.38%)
Insomnia
15 (.38%)
Rash Maculo-papular
15 (.38%)
Aspartate Aminotransferase Increase...
14 (.35%)
Headache
14 (.35%)
Jaundice
14 (.35%)
Mental Disorder
14 (.35%)
Oedema Peripheral
14 (.35%)
Staphylococcal Infection
14 (.35%)
Alanine Aminotransferase Increased
13 (.33%)
Drug Abuse
13 (.33%)
Gamma-glutamyltransferase Increased
13 (.33%)
Head Injury
13 (.33%)
Ill-defined Disorder
13 (.33%)
Inflammation
13 (.33%)
Toxic Epidermal Necrolysis
13 (.33%)
Transient Ischaemic Attack
13 (.33%)
Colitis Ischaemic
12 (.3%)
Dizziness
12 (.3%)
Hyperthermia
12 (.3%)
Intentional Drug Misuse
12 (.3%)
Leukocytosis
12 (.3%)
Neutropenia
12 (.3%)
Rectal Haemorrhage
12 (.3%)
Speech Disorder
12 (.3%)
Tachycardia
12 (.3%)
Upper Limb Fracture
12 (.3%)
Urinary Retention
12 (.3%)
Vertigo
12 (.3%)
Abnormal Sleep-related Event
11 (.28%)
Balance Disorder
11 (.28%)
Convulsion
11 (.28%)
Haematoma
11 (.28%)
International Normalised Ratio Incr...
11 (.28%)
Nervousness
11 (.28%)
Pain
11 (.28%)
Respiratory Distress
11 (.28%)
Sleep Apnoea Syndrome
11 (.28%)
Sleep Disorder
11 (.28%)
Toxic Skin Eruption
11 (.28%)
Tremor
11 (.28%)
Abdominal Pain Upper
10 (.25%)
Cerebral Haematoma
10 (.25%)
Drug Dependence
10 (.25%)
Gait Disturbance
10 (.25%)
Gastrointestinal Haemorrhage
10 (.25%)
Hepatitis Fulminant
10 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Stilnox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Stilnox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Stilnox

What are the most common Stilnox adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Stilnox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Stilnox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Stilnox According to Those Reporting Adverse Events

Why are people taking Stilnox, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
423
Insomnia
356
Sleep Disorder
173
Product Used For Unknown Indication
41
Depression
36
Anxiety
31
Show More Show More
Overdose
13
Schizophrenia
8
Drug Dependence
8
Ill-defined Disorder
8
Sedative Therapy
8
Prophylaxis
7
Somnolence
7
Drug Abuser
6
Intentional Overdose
6
Sleep Disorder Therapy
6
Bipolar I Disorder
5
Agitation
4
Senile Dementia
4
Intentional Misuse
4
Drug Exposure During Pregnancy
4
Suicide Attempt
4
Off Label Use
3
Poisoning
3
Hypnotherapy
3
Sedation
3
Cardiomyopathy
3
Initial Insomnia
3
Bipolar Disorder
3
Multiple Drug Overdose Intentional
2
Unevaluable Event
2
Dysthymic Disorder
2
Multiple Drug Overdose
2
Schizoaffective Disorder
2
Convulsion
2
Pain
2
Gout
2
Accidental Overdose
1
Mental Disorder
1
Middle Insomnia
1
Tachycardia
1
Confusional State
1
Drug Administration Error
1
Obsessive-compulsive Disorder
1
Post Procedural Complication
1
Stress
1
Panic Attack
1
Childhood Psychosis
1
Drug Toxicity
1
Psychotic Disorder
1
Intentional Drug Misuse
1

Stilnox Case Reports

What Stilnox safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Stilnox. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Stilnox.